National D.R.E.S.S. Syndrome Day

United States

About

National D.R.E.S.S. Syndrome Day, observed on July 16, raises awareness of Drug Reaction with Eosinophilia and Systemic Symptoms (D.R.E.S.S.), a rare but potentially serious reaction to certain medications. The condition may cause a widespread rash, fever, swelling, and effects on internal organs, making prompt medical attention especially important.

This observance encourages people to learn about the warning signs, speak openly with healthcare professionals about medication concerns, and support those affected by D.R.E.S.S. syndrome. July 16 is an opportunity to promote greater understanding, earlier recognition, and compassionate care for patients and their families.

History

National D.R.E.S.S. Syndrome Day is observed annually on **July 16** to raise awareness of DRESS syndrome, a rare but potentially life-threatening drug reaction. DRESS stands for **Drug Reaction with Eosinophilia and Systemic Symptoms**. The condition can involve a widespread rash, fever, swelling, abnormal blood counts, and injury to internal organs—especially the liver, kidneys, lungs, or heart. Because its symptoms may resemble an infection or another illness, recognition and prompt medical evaluation are especially important.

The medical history behind the observance reaches back several decades. Severe reactions to anticonvulsant medicines were described before the modern name was adopted, and the illness was once referred to as anticonvulsant hypersensitivity syndrome. In the 1990s, physicians increasingly used the term DRESS to emphasize the characteristic combination of a drug eruption, eosinophilia, and systemic organ involvement. Medical research has since improved understanding of the medications, immune responses, genetic factors, and delayed onset associated with the syndrome.

National D.R.E.S.S. Syndrome Day developed as an awareness-focused observance connected with patient advocacy and efforts to make this uncommon condition better known among the public and healthcare professionals. Its purpose is not simply to mark a medical diagnosis, but also to acknowledge patients and families affected by prolonged, complicated recoveries. Awareness initiatives commonly encourage people to learn the warning signs, keep accurate medication histories, and seek medical advice when serious symptoms develop after starting a drug.

Observed on **July 16**, the day has cultural significance because it gives a relatively rare illness a visible place in the public conversation about medication safety. It also highlights the importance of listening to patients, identifying adverse drug reactions early, and supporting research into diagnosis and treatment. National D.R.E.S.S. Syndrome Day complements—not replaces—professional medical care: anyone who develops a severe rash, fever, facial swelling, breathing difficulty, or other concerning symptoms after taking a medication should seek urgent medical attention.

Timeline

1988
Neil R. Shear and Steven P. Spielberg published a study describing anticonvulsant hypersensitivity syndrome and demonstrating the risk of cross-reactivity among aromatic anticonvulsants, an important predecessor concept to D.R.E.S.S. syndrome.
1996
Jean-Claude Bocquet, Luc Bagot, and Jean-Claude Roujeau introduced the term “drug rash with eosinophilia and systemic symptoms” (DRESS) in a publication on severe drug hypersensitivity reactions.
2013
The RegiSCAR investigators published a study examining variation in severe drug eruptions with systemic symptoms and set out the RegiSCAR scoring approach used to help classify DRESS cases.

Upcoming dates

Sources

Same day

Related